PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi

Bulmus, Ozgur; usta, akin

PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi

Özgür BULMUŞ, (Balıkesir Üniversitesi, Tıp Fakültesi, Fizyoloji Anabilim Dalı, Balıkesir, Türkiye)

Akın USTA (Balıkesir Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Balıkesir, Türkiye)

Balıkesir Sağlık Bilimleri Dergisi (BSBD)

3 3

Yıl: 2022 Cilt: 11 Sayı: 1 Sayfa Aralığı: 136 - 142 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi

Öz:

Amaç: Polikistik over sendromlu (PKOS) hastalarda kan basıncı (KB) anormalliklerine sıklıkla rastlanmakla beraber hipertansiyon ve PKOS arasındaki ilişki tam olarak aydınlatılamamıştır. Bu çalışmadaki amacımız ACC/AHA tarafından önerilen yeni sınıflandırmaya göre PKOS’lu hastalarda KB değişikliklerini araştırmaktır. Gereç Yöntem: Çalışmada PKOS tanılı 64 hasta ile aynı yaş grubundaki PKOS olmayan 61 hastanın KB ölçümleri ve bazal karakteristik özellikleri birbiri ile karşılaştırıldı. Bulgular: Kontrol grubuyla karşılaştırıldığında, PKOS hastalarının Ferriman Gallwey skoru (p<0.0001), ortalama diyastolik kan basıncı (p= 0.0099), glukoz (p=0.0049), lökosit (p= 0.0319), nötrofil (p=0.0364) ve Lüteinizan Hormon (LH) (p=0.0018) seviyeleri istatistiksel anlamlı olarak daha yüksek bulundu. PKOS ve Kontrol grubu ACC/AHA klavuzuna göre gruplandırıldığında PKOS hastalarının %59.4’ü anormal KB sahipken kontrol grubundaki hastaların ise %47.5’inde anormal KB tespit edildi. Yapılan istatistik analizde gruplar arasında anlamlı fark tespit edildi (p=0.0343). PKOS hastalarında DKB seviyeleri ile VKİ, serum glukoz seviyesi, HOMA-IR, total kolesterol ve LDL kolesterol arasında pozitif korelasyon tespit edildi. Ayrıca PKOS hastalarında DKB ile HDL kolesterol seviyeleri arasında negatif korelasyon tespit edildi. Sonuç: Üreme dönemindeki PKOS hastalarında KB (özellikle DKB) seviyelerinin insülin direnci, hiperandrojenemi ve dislipideminin varlığıyla ilişkili olarak yükselme eğiliminde olduğu, fakat PKOS ve kontrol grubu arasında hipertansiyon görülme sıklığı açısından fark olmadığı tespit edilmiştir.

Anahtar Kelime: PKOS ACC/AHA Guideline Sınıflaması Hipertansiyon

The Incidance of High Blood Pressure in Women with PCOS and Its Correlation with Clinical and Biochemical Parameters

Öz:

Aim: Although blood pressure abnormalities are frequently encountered in patients with polycystic ovary syndrome (PCOS), the relationship between hypertension and PCOS has not been fully elucidated. Our aim of this study is to investigate BP alteration in patients with PCOS according to the new classification proposed by ACC/AHA guideline. Material and Methods: In this study, we compared the BP measurements and baseline characteristics of 64 patients with PCOS and 61 patients without PCOS in the same age group. Results: Compared with the control group, PCOS patients had increased Ferriman Gallwey score (p<0.0001), mean diastolic blood pressure (p=0.0099), glucose levels (p=0.0049), leukocyte counts (p=0.0319), neutrophil counts (p=0.0364) and LH levels (p=0.0018). When the PCOS and Control patients were classified according to the ACC/AHA guideline, 59.4% of the PCOS patients had abnormal BP, while 47.5% of the patients in the control group had abnormal BP. There was a statistically significant differences between the groups (p=0.0343).The correlation analysis showed that there were positive correlation between DBP levels and BMI, serum glucose level, HOMA-IR, total cholesterol and LDL cholesterol in PCOS patients. In addition, there was a negative correlation between DKB and HDL cholesterol levels in PCOS patients. Conclusion: It has been determined that BP (especially DBP) levels tend to increase in PCOS patients in the reproductive period in relation to the presence of insulin resistance, hyperandrogenemia and dyslipidemia, but there is no difference in the incidence of hypertension between PCOS and control groups.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Alexander, C.J., Tangchitnob, E.P., & Lepor, N.E. (2009). Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Reviews in Obstetrics and Gynecology, 2(4), 232-239.
Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Human Reproduction, 27(1), 14- 24. https://doi.org/ 10.1093/humrep/der396
Azziz, R., Woods, K.S., Reyna, R., Key, T.J., Knochenhauer, E.S., & Yildiz, B.O. (2004). The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2745-2749. https://doi.org/10.1210/jc.2003-032046
Bentley-Lewis, R., Seely, E., & Dunaif, A. (2011). Ovarian hypertension: polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America, 40(2), 433-449. https://doi.org/10.1016/j.ecl.2011.01.009
Boomsma, C.M., Fauser, B.C., & Macklon, N.S. (2008). Pregnancy complications in women with polycystic ovary syndrome. Seminars in Reproductive Medicine, 26(1), 72-84. https://doi.org/10.1055/s-2007-992927
Burghen, G.A., Givens, J.R., & Kitabchi, A.E. (1980). Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. The Journal of Clinical Endocrinology & Metabolism, 50(1), 113-116. https://doi.org/ 10.1210/jcem-50-1-113
Carmina, E. (2009). Cardiovascular risk and events in polycystic ovary syndrome. Climacteric, 12 (Suppl 1), 22-25. https://doi.org/ 10.1080/13697130903003842
Conway, G.S., Agrawal, R., Betteridge, D.J., & Jacobs, H.S. (1992). Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clinical Endocrinology 37(2), 119-125. https://doi.org/ 10.1111/j.1365-2265.1992.tb02295.x
Diamanti-Kandarakis, E., Alexandraki, K., Piperi, C., Aessopos, A., Paterakis T, Katsikis I., & Panidis, D. (2007). Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome. Metabolism, 56(1), 129-134. https://doi.org/ 10.1016/j.metabol.2006.09.006
Elting, M.W., Korsen, T.J., Bezemer, P.D., & Schoemaker J. (2001). Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Human Reproduction, 16(3), 556-560. https://doi.org/ 10.1093/humrep/16.3.556
Ferriman, D., & Gallwey, J.D. (1961). Clinical assessment of body hair growth in women. The Journal of Clinical Endocrinology & Metabolism, 21, 1440-1447. https://doi.org/ 10.1210/jcem-21-11-1440
Guo, X., Zhang, X., Guo, L., Li, Z., Zheng, L., Yu, S., Yang, H., Zhou, X., Zhang, X., Sun, Z., Li, J., Sun, Y. (2013). Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Current Hypertension Reports, 15(6), 703-716. https://doi.org/ 10.1007/s11906-013-0403-y
Guo, X., Zhang, X., Zheng, L., Guo, L., Li, Z., Yu, S., Yang, H., Zhou, X., Zou, L., Zhang, X., Sun, Z., Li, J., & Sun, Y. (2013). Prehypertension is not associated with all-cause mortality: a systematic review and meta-analysis of prospective studies. PLoS One, 8(4), e61796. https://doi.org/10.1371/journal.pone.0061796
Huang, Y., Cai, X., Li, Y., Su, L., Mai, W., Wang, S., Hu, Y., Wu, Y., & Xu, D. (2014). Prehypertension and the risk of stroke: a meta-analysis. Neurology, 82(13), 1153-1161. https://doi.org/ 10.1161/JAHA.114.001519
Huang, Y., Cai, X., Liu, C., Zhu, D., Hua, J., Hu, Y., Peng, J., & Xu, D. (2015). Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. Journal of the American Heart Association, 4(2), e001519. https://doi.org/ 10.1161/JAHA.114.001519
Huang, Y., Cai, X., Zhang, J., Mai, W., Wang, S., Hu, Y., Ren, H., & Xu, D. (2014). Prehypertension and incidence of ESRD: a systematic review and metaanalysis. American Journal of Kidney Diseases, 63(1), 76-83. https://doi.org/ 10.1053/j.ajkd.2013.07.024
Joham, A.E., Boyle, J.A., Zoungas, S., & Teede, H.J. (2015). Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity. American Journal of Hypertension, 28(7), 847-851. https://doi.org/ 10.1093/ajh/hpu251
Keskin Kurt, R., Okyay, A.G., Hakverdi, A.U., Gungoren, A., Dolapcioglu, K.S., Karateke, A., & Dogan, M.O. (2014). The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched casecontrol study. Archives of Gynecology and Obstetrics, 290(2), 315-319. https://doi.org/ 10.1007/s00404-014-3199-3
Laffin, L.J., & Bakris, G.L. (2015). Hypertension and new treatment approaches targeting the sympathetic nervous system. Current Opinion in Pharmacology, 21, 20-24. https://doi.org/ 10.1016/j.coph.2014.12.006
Lewington, S., Clarke, R., Qizilbash, N., Peto, R., & Collins, R. (2002). Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360, 1903-1913. https://doi.org/ 10.1016/s0140-6736(02)11911-8
Lo, J.C., Feigenbaum, S.L., Yang, J., Pressman, A.R., Selby, J.V., & Go, A.S. (2006). Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 91(4), 1357-1363. https://doi.org/ 10.1210/jc.2005-2430
Lord, J.M., Flight, I.H.K., & Norman, R.J. (2003). Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ, 327(7421), 951-953. https://doi.org/ 10.1136/bmj.327.7421.951
Meyer, C., McGrath, B.P., & Teede, H.J. (2005). Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. The Journal of Clinical Endocrinology & Metabolism, 90(10), 5711-5716. https://doi.org/ 10.1210/jc.2005-0011
Orbetzova, M.M., Shigarminova, R.G., Genchev, G.G., Milcheva, B.A., Lozanov, L.B., Genov, N.S., & Zacharieva, S.Z. (2003). Role of 24-hour monitoring in assessing blood pressure changes in polycystic ovary syndrome. Folia Medica, 45(3), 21-25.
Orio F Jr, Palomba S, Cascella T, De Simone B, Manguso F, Savastano S, Russo T, Tolino A, Zullo F, Lombardi G, Azziz R, Colao A. (2005). Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. The Journal of Clinical Endocrinology & Metabolism, 90(11), 6072-3076. https://doi.org/10.1210/jc.2005-0965
Poulter, N.R., Prabhakaran, D., & Caulfield, M. (2015). Hypertension. Lancet, 386(9995), 801-812. https://doi.org/ 10.1016/S0140-6736(14)61468-9
Sirmans, S.M., & Pate, K.A. (2014). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology, 6, 1-13. https://doi.org/ 10.2147/CLEP.S37559
Stein, I.F., & Leventhal, M.L. (1935). Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics & Gynecology, 29(2), 181-191. https://doi.org/ 10.1016/S0002-9378(15)30642-6
Talbott, E., Clerici, A., Berga, S.L., Kuller, L., Guzick, D., Detre, K., Daniels, T., & Engberg, R.A. (1998). Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. Journal of Clinical Epidemiology, 51(5), 415-422. Doi: https://doi.org/ 10.1016/s0895-4356(98)00010- 9
Vrbíková, J., Cífková, R., Jirkovská, A., Lánská, V., Platilová, H., Zamrazil, V., & Stárka, L. (2003). Cardiovascular risk factors in young Czech females with polycystic ovary syndrome. Human Reproduction, 18(5), 980-984. https://doi.org/10.1093/humrep/deg218
Whelton, P.K., Carey, R.M., Aronow, W.S., Casey, D.E., Collins, K.J., Dennison Himmelfarb, C., DePalma, S.M., Gidding, S., Jamerson, K.A., Jones, D.W., MacLaughlin E.J., Muntner P., et al. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 71(19), e127-e248. https://doi.org/10.1016/j.jacc.2017.11.006
Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H.F., Futterweit, W., Lobo, R., Norman, R.J., Talbott, E., & Dumesic, D.A. (2010). Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. The Journal of Clinical Endocrinology & Metabolism, 95(5), 2038-2049. https://doi.org/ 10.1210/jc.2009-2724
Wild, S., Pierpoint, T., Jacobs, H., & McKeigue, P. (2000). Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Human Fertility 3(2), 101-105. https://doi.org/ 10.1080/1464727002000198781
Willey JZ, Moon YP, Kahn E, Rodriguez CJ, Rundek T, Cheung K, Sacco RL, Elkind MSV. (2014). Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. Journal of the American Heart Association, 3(5), e001106. https://doi.org/ 10.1161/JAHA.114.001106
Zimmermann, S., Phillips, R.A., Dunaif, A., Finegood, D.T., Wilkenfeld, C., Ardeljan, M., Gorlin, R., Krakoff, L.R. (1992). Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. The Journal of Clinical Endocrinology & Metabolism, 75(2), 508-513. https://doi.org/10.1210/jcem.75.2.1639952

APA	Bulmus O, usta a (2022). PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. , 136 - 142.
Chicago	Bulmus Ozgur,usta akin PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. (2022): 136 - 142.
MLA	Bulmus Ozgur,usta akin PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. , 2022, ss.136 - 142.
AMA	Bulmus O,usta a PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. . 2022; 136 - 142.
Vancouver	Bulmus O,usta a PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. . 2022; 136 - 142.
IEEE	Bulmus O,usta a "PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi." , ss.136 - 142, 2022.
ISNAD	Bulmus, Ozgur - usta, akin. "PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi". (2022), 136-142.

APA	Bulmus O, usta a (2022). PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. Balıkesir Sağlık Bilimleri Dergisi (BSBD), 11(1), 136 - 142.
Chicago	Bulmus Ozgur,usta akin PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. Balıkesir Sağlık Bilimleri Dergisi (BSBD) 11, no.1 (2022): 136 - 142.
MLA	Bulmus Ozgur,usta akin PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. Balıkesir Sağlık Bilimleri Dergisi (BSBD), vol.11, no.1, 2022, ss.136 - 142.
AMA	Bulmus O,usta a PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. Balıkesir Sağlık Bilimleri Dergisi (BSBD). 2022; 11(1): 136 - 142.
Vancouver	Bulmus O,usta a PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi. Balıkesir Sağlık Bilimleri Dergisi (BSBD). 2022; 11(1): 136 - 142.
IEEE	Bulmus O,usta a "PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi." Balıkesir Sağlık Bilimleri Dergisi (BSBD), 11, ss.136 - 142, 2022.
ISNAD	Bulmus, Ozgur - usta, akin. "PKOS Hastalarında Yüksek Kan Basıncı Sıklığı ve Bunun Klinik ve Laboratuvar Parametrelerle İlişkisi". Balıkesir Sağlık Bilimleri Dergisi (BSBD) 11/1 (2022), 136-142.